Soulafa Mamlouk

951 total citations
17 papers, 355 citations indexed

About

Soulafa Mamlouk is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Soulafa Mamlouk has authored 17 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 10 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Soulafa Mamlouk's work include Cancer Genomics and Diagnostics (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). Soulafa Mamlouk is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). Soulafa Mamlouk collaborates with scholars based in Germany, Switzerland and Finland. Soulafa Mamlouk's co-authors include Ben Wielockx, Joanna Kalucka, Kristin Franke, Georg Breier, Rashim Pal Singh, Christine Sers, David Horst, David M. Poitz, Anne Klotzsche–von Ameln and Hendrik Bläker and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Bioinformatics.

In The Last Decade

Soulafa Mamlouk

17 papers receiving 348 citations

Peers

Soulafa Mamlouk

ONCOL

GENET

PRM

Zexuan Liu China

Ulrike Hopfer Germany

Yoko Sekita Japan

Rhyannon Spangler United States

Xiaoyan Lin China

Ruth Schietke Germany

Dongtao Fu United States

M. Ángeles Villaronga Spain

Hongxia Sun United States

Audrey Sermeus Belgium

Zexuan Liu China

Soulafa Mamlouk

145 ×0.7

197 ×1.1

69 ×0.8

ONCOL

36 ×0.8

GENET

30 ×0.7

PRM

Citations per year, relative to Soulafa Mamlouk Soulafa Mamlouk (= 1×) peers Zexuan Liu

Countries citing papers authored by Soulafa Mamlouk

Since Specialization

Citations

This map shows the geographic impact of Soulafa Mamlouk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soulafa Mamlouk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soulafa Mamlouk more than expected).

Fields of papers citing papers by Soulafa Mamlouk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soulafa Mamlouk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soulafa Mamlouk. The network helps show where Soulafa Mamlouk may publish in the future.

Co-authorship network of co-authors of Soulafa Mamlouk

This figure shows the co-authorship network connecting the top 25 collaborators of Soulafa Mamlouk. A scholar is included among the top collaborators of Soulafa Mamlouk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soulafa Mamlouk. Soulafa Mamlouk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Stahler, Arndt, Christine Sers, Soulafa Mamlouk, et al.. (2024). Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212). Clinical Cancer Research. 30(7). 1256–1263. 9 indexed citations

Prado‐Lòpez, Sonia, Nuria Estévez‐Gómez, Dominik Geisel, et al.. (2022). Clonality and timing of relapsing colorectal cancer metastasis revealed through whole-genome single-cell sequencing. Cancer Letters. 543. 215767–215767. 10 indexed citations

Bashir, Sanum, Ralf Kühn, Markus F. Templin, et al.. (2022). A RAS-independent biomarker panel pedicts response to MEK-inhibitors in colorectal cancer.. Journal of Clinical Oncology. 40(16_suppl). e15524–e15524. 1 indexed citations

Bashir, Sanum, Ralf Kühn, Markus F. Templin, et al.. (2022). A RAS-Independent Biomarker Panel to Reliably Predict Response to MEK Inhibition in Colorectal Cancer. Cancers. 14(13). 3252–3252. 10 indexed citations

Modest, Dominik Paul, Christine Sers, Soulafa Mamlouk, et al.. (2022). Negative hyperselection for mutations associated with anti-EGFR antibody resistance in RAS wildtype metastatic colorectal cancer (mCRC): Evaluation of the PANAMA trial (AIO-KRK-0212, maintenance therapy with 5-FU, folinic acid (FU/FA) with or without panitumumab).. Journal of Clinical Oncology. 40(16_suppl). 3536–3536. 2 indexed citations

Arnold, Alexander, Christine Sers, Aysel Ahadova, et al.. (2020). The majority of β-catenin mutations in colorectal cancer is homozygous. BMC Cancer. 20(1). 1038–1038. 28 indexed citations

Mamlouk, Soulafa, David C. Wedge, Alexander Arnold, et al.. (2020). Malignant transformation and genetic alterations are uncoupled in early colorectal cancer progression. BMC Biology. 18(1). 116–116. 12 indexed citations

Klotz‐Noack, Kathleen, Bertram Klinger, Johannes Zuber, et al.. (2020). Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe. Cell Death and Disease. 11(7). 499–499. 5 indexed citations

Sers, Christine, et al.. (2019). Robust in-silico identification of Cancer Cell Lines based on RNA and targeted DNA sequencing data. Scientific Reports. 9(1). 367–367. 2 indexed citations

10.

Jurmeister, Philipp, Anne Schöler, Alexander Arnold, et al.. (2019). DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer. Modern Pathology. 32(6). 855–865. 38 indexed citations

11.

Childs, Liam, Soulafa Mamlouk, Jørgen Brandt, Christine Sers, & Ulf Leser. (2016). SoFIA: a data integration framework for annotating high-throughput datasets. Bioinformatics. 32(17). 2590–2597. 6 indexed citations

12.

Mamlouk, Soulafa, Joanna Kalucka, Rashim Pal Singh, et al.. (2013). Loss of prolyl hydroxylase‐2 in myeloid cells and T‐lymphocytes impairs tumor development. International Journal of Cancer. 134(4). 849–858. 29 indexed citations

13.

Singh, Rashim Pal, Kristin Franke, Joanna Kalucka, et al.. (2013). HIF prolyl hydroxylase 2 (PHD2) is a critical regulator of hematopoietic stem cell maintenance during steady-state and stress. Blood. 121(26). 5158–5166. 34 indexed citations

14.

Kalucka, Joanna, Andreas Ettinger, Kristin Franke, et al.. (2013). Loss of Epithelial Hypoxia-Inducible Factor Prolyl Hydroxylase 2 Accelerates Skin Wound Healing in Mice. Molecular and Cellular Biology. 33(17). 3426–3438. 49 indexed citations

15.

Mamlouk, Soulafa & Ben Wielockx. (2012). Hypoxia‐inducible factors as key regulators of tumor inflammation. International Journal of Cancer. 132(12). 2721–2729. 52 indexed citations

16.

Ameln, Anne Klotzsche–von, Soulafa Mamlouk, Joanna Kalucka, et al.. (2011). Inhibition of HIF Prolyl Hydroxylase-2 Blocks Tumor Growth in Mice through the Antiproliferative Activity of TGFβ. Cancer Research. 71(9). 3306–3316. 62 indexed citations

17.

Yeghiazaryan, Kristina, Soulafa Mamlouk, Daniela Trog, et al.. (2008). Irradiated breast cancer patients demonstrate subgroup-specific regularities in protein expression patterns of circulating leukocytes.. PubMed. 4(6). 411–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact